Advocacy and Public Pressure: Patient advocacy groups and professional medical organizations will continue to exert increasing pressure on state and federal lawmakers over time
Kidney disease: Youll need more frequent kidney function tests
Repeated intracerebroventricular administration of glucagon-like peptide-1-736 amide or exendin939 alters body weight in the rat
Perna, S., Guido, D., Bologna, C., Solerte, S
Semaglutide also tends to produce more rapid and substantial weight loss than older GLP-1 medications, which aligns with the weight-loss-driven telogen effluvium hypothesis
Insights from Andrew Huberman and Joe Rogan: Gain insights into why Andrew Huberman, a respected neuroscientist and educator, is intrigued by the potential of BPC 157